Evidence map›Paper›PMID 39573994›Full record

ReviewBMC infectious diseases2024

Federated learning as a smart tool for research on infectious diseases.

Laura C Zwiers, Diederick E Grobbee, Alicia Uijl, David S Y Ong

Abstract readReview
In one paragraph

Review in BMC infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. AI-Prediction ofHealthcare (Basel, Switzerland) · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Laura C ZwiersJulius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. laura.zwiers@juliusclinical.com.ORCID http://orcid.org/0009-0000-4080-6541
Diederick E GrobbeeJulius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-4472-4468
Alicia UijlJulius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-2835-7741
David S Y OngJulius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0001-5688-6443

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of real-world data has become increasingly popular, also in the field of infectious disease (ID), particularly since the COVID-19 pandemic emerged. While much useful data for research is being collected, these data are generally stored across different sources. Privacy concerns limit the possibility to store the data centrally, thereby also limiting the possibility of fully leveraging the potential power of combined data. Federated learning (FL) has been suggested to overcome privacy issues by making it possible to perform research on data from various sources without those data leaving local servers. In this review, we discuss existing applications of FL in ID research, as well as the most relevant opportunities and challenges of this method.

methodsReferences for this review were identified through searches of MEDLINE/PubMed, Google Scholar, Embase and Scopus until July 2023. We searched for studies using FL in different applications related to ID.

resultsThirty references were included and divided into four sub-topics: disease screening, prediction of clinical outcomes, infection epidemiology, and vaccine research. Most research was related to COVID-19. In all studies, FL achieved good accuracy when predicting diseases and outcomes, also in comparison to non-federated methods. However, most studies did not make use of real-world federated data, but rather showed the potential of FL by using data that was manually partitioned.

conclusionsFL is a promising methodology which allows using data from several sources, potentially generating stronger and more generalisable results. However, further exploration of FL application possibilities in ID research is needed.

Indexed as

Communicable DiseasesCOVID-19Biomedical ResearchHumansSARS-CoV-2AIBig dataFederated learningInfectionMachine learningVaccine

Identifiers

PMID39573994
PMCPMC11580691

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.